Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Efficacy and tolerability of multidrug therapy for hypertriglyceridemia
Venkateshwar R. Polsani
, Vijay Nambi
, Salim S. Virani
, Danièle Zoch
,
Eric Y. Yang
, Peter H. Jones
, Christie M. Ballantyne
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and tolerability of multidrug therapy for hypertriglyceridemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Body Mass
25%
Combination Drug
50%
Combination Therapy
25%
Drug
50%
Drug Therapy
50%
Follow up
50%
Hemoglobin
25%
Hospital
25%
Hypertriglyceridemia
100%
Inpatient
50%
Lipid
50%
Parameters
25%
Patient Referral
25%
Polypharmacy
50%
Procedures
25%
Time
25%
Total Cholesterol Level
25%
Triacylglycerol Level
50%
Medicine and Dentistry
Chemotherapeutic Agent
50%
Combination Therapy
25%
Drug
50%
Drug Therapy
25%
Follow up
50%
Hemoglobin
25%
Hypertriglyceridemia
100%
Lipid
50%
Patient Referral
25%
Patient with Diabetes
50%
Polypharmacy
50%
Therapeutic Procedure
25%
Biochemistry, Genetics and Molecular Biology
Body Mass
25%
Hemoglobin
25%
Hypertriglyceridemia
100%
Lipid
50%
Reduction (Chemistry)
25%
Time
25%
Total Cholesterol Level
25%
Triacylglycerol Level
50%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
25%
Drug
50%
Hemoglobin
25%
Hypertriglyceridemia
100%
Lipid
50%
Tolerability
25%